Nura Bio reels in $73m Series A

South San Francisco-based Nura Bio Inc, a biopharma company focused on developing neuroprotective drugs, has raised $73 million in Series A funding.

South San Francisco-based Nura Bio Inc, a biopharma company focused on developing neuroprotective drugs, has raised $73 million in Series A funding. The Column Group led the round with participation from Samsara BioCapital and Euclidean Capital.

Source: Press Release